Loading…

Choice of Tyrosine Kinase Inhibitor and Early Events during the First Year of Therapy in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia (CML) Patients with Concomitant Diabetes: A "Campus CML" Study

Saved in:
Bibliographic Details
Published in:Blood 2022-11, Vol.140 (Supplement 1), p.3920-3922
Main Authors: Capodanno, Isabella, Tiribelli, Mario, Miggiano, Maria Cristina, Bucelli, Cristina, Cavazzini, Francesco, Leonetti Crescenzi, Sabrina, Russo, Sabina, Scalzulli, Emilia, Bernardelli, Andrea, Luciano, Luigiana, Mulas, Olga, Loglisci, Giuseppina, Elena, Chiara, Pizzano, Umberto, Attolico, Immacolata, Binotto, Gianni, CrisĂ , Elena, Sportoletti, Paolo, Di Veroli, Ambra, Scortechini, Anna Rita, Leporace, Annapaola, Basile, Maria, Crugnola, Monica, Stagno, Fabio, Murgano, Pamela, Rapezzi, Davide, Luzi, Debora, Iurlo, Alessandra, Bocchia, Monica, Fava, Carmen, Malato, Alessandra, Galimberti, Sara, Vincelli, Iolanda Donatella, Trawinska, Malgorzata Monika, Pizzuti, Michele, Caocci, Giovanni, Bonifacio, Massimiliano, Saglio, Giuseppe, Specchia, Giorgina, Breccia, Massimo, Latagliata, Roberto
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2022-164790